These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immune reactivity towards insulin, its amyloid and protein S100B in blood sera of Parkinson's disease patients. Wilhelm KR; Yanamandra K; Gruden MA; Zamotin V; Malisauskas M; Casaite V; Darinskas A; Forsgren L; Morozova-Roche LA Eur J Neurol; 2007 Mar; 14(3):327-34. PubMed ID: 17355556 [TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias. Maetzler W; Berg D; Synofzik M; Brockmann K; Godau J; Melms A; Gasser T; Hörnig S; Langkamp M J Alzheimers Dis; 2011; 26(1):171-9. PubMed ID: 21593566 [TBL] [Abstract][Full Text] [Related]
6. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734 [TBL] [Abstract][Full Text] [Related]
7. Nasal inoculation with α-synuclein aggregates evokes rigidity, locomotor deficits and immunity to such misfolded species as well as dopamine. Gruden MA; Davidova TV; Yanamandra K; Kucheryanu VG; Morozova-Roche LA; Sherstnev VV; Sewell RD Behav Brain Res; 2013 Apr; 243():205-12. PubMed ID: 23333843 [TBL] [Abstract][Full Text] [Related]
8. Viral vector-mediated overexpression of α-synuclein as a progressive model of Parkinson's disease. Ulusoy A; Decressac M; Kirik D; Björklund A Prog Brain Res; 2010; 184():89-111. PubMed ID: 20887871 [TBL] [Abstract][Full Text] [Related]
9. Increased S100B+ NK cell counts in acutely ill schizophrenia patients are correlated with the free cortisol index, but not with S100B serum levels. Steiner J; Westphal S; Schroeter ML; Schiltz K; Jordan W; Müller UJ; Bernstein HG; Bogerts B; Schmidt RE; Jacobs R Brain Behav Immun; 2012 May; 26(4):564-7. PubMed ID: 22326439 [TBL] [Abstract][Full Text] [Related]
15. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease? Chu Y; Kordower JH Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279 [TBL] [Abstract][Full Text] [Related]
16. Analysis of some peripheral blood lymphocyte subsets in relation to Borrelia burgdorferi antibodies in patients with Lyme disease. Zajkowska JM; Hermanowska-Szpakowicz T; Wysocka J; Kondrusik M; Pancewicz SA; Grygorczuk S Rocz Akad Med Bialymst; 2000; 45():184-98. PubMed ID: 11712430 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease. Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678 [TBL] [Abstract][Full Text] [Related]
18. Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model. Febbraro F; Andersen KJ; Sanchez-Guajardo V; Tentillier N; Romero-Ramos M Exp Neurol; 2013 Sep; 247():45-58. PubMed ID: 23531432 [TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder? Olanow CW; Brundin P Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095 [TBL] [Abstract][Full Text] [Related]